The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Sp78
A MULTIVALENT NUCLEOSIDE-MODIFIED MRNA-LNP VACCINE FOR CLOSTRIDIODIES DIFFICILE
BACKGROUND: As outlined by the Kyoto guidelines, targeted DNA-based NGS of pancreatic cyst fluid (PCF) is an important adjunct to the evaluation of pancreatic cyst patients…
SOCIETY: AGA This session will feature cutting-edge research on the multifaceted aspects of Clostridioides difficile colitis, presenting the latest findings in pathogenesis and innovative therapeutic approaches. Attendees will gain valuable insights into the molecular and immunological aspects of C…
BACKGROUND: Recent studies suggest links between _Clostridioides difficile_ infection (CDI) and liver disorders, with non-alcoholic fatty liver disease (NAFLD) increasing CDI risk and CDI exacerbating the progression and prognosis of liver cirrhosis. Moreover, gut dysbiosis, often leading to _C…